Proteomics: New insights into rheumatic diseases

Proteomics - Clinical Applications

Volumn 3, Issue 2, 2009, Pages 226-241

  Camafeita, Emilio ^a   Lamas, José Ramón ^b   Calvo, Enrique ^a   López, Juan Antonio ^a   Fernández Gutiérrez, Benjamín ^b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Arthritis; Biomarker; Cartilage; Mass spectrometry; Osteoarthritis

Indexed keywords

ALPHA ENOLASE; AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN B; CELL PROTEIN; FIBULIN; FIBULIN 4; GELATINASE B; GLUCOSE 6 PHOSPHATE ISOMERASE; LYSOPHOSPHATIDYLCHOLINE; MATRIX PROTEIN; MYELOID RELATED PROTEIN 8; MYELOPEROXIDASE; PHOSPHATIDYLCHOLINE; PLASMINOGEN ACTIVATOR; PROTEIN S 100; PROTEIN SF; PROTEOGLYCAN; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ARTHROPATHY; AUTOIMMUNITY; CELL ACTIVITY; CELL COMMUNICATION; CELL METABOLISM; CHROMATOGRAPHY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HYDROPHOBICITY; IMMUNE RESPONSE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUSCULOSKELETAL SYSTEM; OSTEOARTHRITIS; OSTEOPOROSIS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN QUALITY; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 65549162015     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800146     Document Type: Review

References (100)

1. Bansback, N. J., Regier, D. A., Ara, R., Brennan, A. et al., An overview of economic evaluations for drugs used in rheumatoid arthritis: Focus on tumour necrosis factor-alpha antagonists. Drugs 2005, 65, 473-496.
2. Loza, E., Abasolo, L., Jover, J. A., Carmona, L., Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life. J. Rheumatol. 2008, 35, 159-165.
3. Worthington, J., Investigating the genetic basis of susceptibility to rheumatoid arthritis. J. Autoimmun. 2005, 25, 16-20.
4. Lopez de Castro, J. A., HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol. Lett. 2007, 108, 27-33.
5. Allanore, Y., Wipff, J., Kahan, A., Boileau, C., Genetic basis for systemic sclerosis. Joint Bone Spine 2007, 74, 577-583.
6. Manners, P. J., Epidemiology of the rheumatic diseases of childhood. Curr. Rheumatol. Rep. 2003, 5, 453-457.
7. Gates, C. B., Karthikeyan, T., Fu, F., Huard, J., Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J. Am. Acad. Orthop. Surg. 2008, 16, 68-76.
8. McGonagle, D., De Bari, C., Arnold, P., Jones, E., Lessons from musculoskeletal stem cell research: the key to successful regenerative medicine development. Arthritis Rheum. 2007, 56, 714-721.
9. Kimelman, N., Pelled, G., Helm, G. A., Huard, J. et al., Lessons from musculoskeletal stem cell research: The key to successful regenerative medicine development. Tissue Eng. 2007, 13, 1135-1150.
10. Begovich, A. B., Carlton, V. E., Honigberg, L. A., Schrodi, S. J. et al., A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004, 75, 330-337.
11. Prokunina, L., Castillejo-López, C., Oberg, F., Gunnarsson, I. et al., A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 2002, 32, 666-669.
12. Dominguez, D. C., Lopes, R., Torres, M. L., Proteomics: Clinical applications. Clin. Lab. Sci. 2007, 20, 245-248.
13. de Hoog, C. L., Mann, M., Proteomics. Annu. Rev. Genomics Hum. Genet. 2004, 5, 267-293.
14. Müller-Ladner, U., Pap, T., Gay, R. E., Neidhart, M., Gay, S., Mechanisms of disease: The molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2005, 1, 102-110.
15. Ochi, S., Shinohara, M., Sato, K., Gober, H. J. et al., Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc. Natl. Acad. Sci. USA 2007, 104, 11394-11399.
16. Coligan, J. E., Dunn, B. M., Speicher, D. W., Wingfield, P. T. (Eds.), Current Protocol in Protein Science, John Wiley & Sons, Inc., Hoboken, NJ 2008.
17. Yu, C., Cohen, L. H., Tissue sample preparation-not the same old grind. LC-GC Europe 2004, 1, 2-6.
18. Hanash, S., 2-D or not 2-D: Is there a future for 2-D gels in proteomics? Insights from the York Proteomics meeting. Proteomics 2001, 1, 635-637.
19. Unlu, M., Morgan, M. E, Minden, J. S., Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
20. Boysen, R. I., Hearn, M. T., HPLC of peptides and proteins. Curr. Protoc. Protein Sci. 2001, 23, 8.7.1-8.7.40.
21. Liao, H, Wu, J., Kuhn, E., Chin, W. et al., Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50, 3792-3803.
22. Issaq, H. J., Veenstra, T. D., Conrads, T. P., Felschow, D., The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002, 292, 587-592.
23. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
24. Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B. et al., Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8, 295-301.
25. Goldring, M. B., Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract. Res. Clin. Rheumatol. 2006, 20, 1003-1025.
26. Hermansson, M., Sawaji, Y., Bolton, M., Alexander, S. et al., Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin A (activin A), a regulatory molecule for chondrocytes. J. Biol. Chem. 2004, 279, 43514-43521.
27. Vincourt, J. B., Lionneton, F., Kratassiouk, G., Guillemin, F. et al., Establishment of a reliable method for direct proteome characterization of human articular cartilage. Mol. Cell. Proteomics 2006, 5, 1984-1995.
28. Wilson, R., Belluoccio, D., Bateman, J. F., Proteomic analysis of cartilage proteins. Methods 2008, 45, 22-31.
29. Garcia, B. A., Platt, M. D., Born, T. L., Shabanowitz, J. et al., Protein profile of osteoarthritic human articular cartilage using tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 2999-3006.
30. Tew, S. R., Murdoch, A. D., Rauchenberg, R. P., Hardingham, T. E., Cellular methods in cartilage research: Primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods 2008, 45, 2-9.
31. Thirion, S., Berenbaum, F., Culture and phenotyping of chondrocytes in primary culture. Methods Mol. Med. 2004, 100, 1-14.
32. Freyria, A. M., Becchi, M., Changes of chondrocyte metabolism in vitro: An approach by proteomic analysis. Methods Mol. Med. 2004, 100, 165-182.
33. Ruiz-Romero, C., Lopez-Armada, M. J., Blanco, F. J., Proteomic characterization of human normal articular chondrocytes: A novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics 2005, 5, 3048-3059.
34. Ruiz-Romero, C., Lopez-Armada, M. J., Blanco, F. J., Mitochondrial proteomic characterization of human normal chondrocytes. Osteoarthr. Cartil. 2006, 14, 507-518.
35. Ruiz-Romero, C., Carreira, V., Rego, I., Remeseiro, S. et al., Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 2008, 8, 495-507.
36. López-Armada, M. J., Caramés, B., Lires-Deán, M., Cillero-Pastor, B. et al., Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthr. Cartil. 2006, 14, 660-669.
37. De Ceuninck, F., Dassencourt, L., Anract, P., The inflammatory side of human chondrocytes unveiled by antibody microarrays. Biochem. Biophys. Res. Commun. 2004, 323, 960-969.
38. Catterall, J. B., Rowan, A. D., Sarsfield, S., Saklatvala, J. et al., Development of a novel 2-D proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by IL-1 and oncostatin M. Rheumatology 2006, 45, 1101-1109.
39. Dasuri, K., Antonovici, M., Chen, K., Wong, K. et al., The synovial proteome: Analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 2004, 6, R161-R168.
40. Blass, S., Union, A., Raymackers, J., Schumann, F. et al., The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001, 44, 761-771.
41. Saulot, V., Vittecoq, O., Charlionet, R., Fardellone, P. et al., Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002, 46, 1196-1201.
42. Kinloch, A., Tatzer, V., Wait, R., Peston, D. et al., Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7, R1421-R1419.
43. Matsuo, K., Xiang, Y., Nakamura, H., Masuko, K. et al., Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther. 2006, 8, R175.
44. Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J. et al., Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2005, 52, 2645-2655.
45. Hueber, W., Tomooka, B. H., Zhao, X., Kidd, B. A. et al., Proteomic analysis of secreted proteins in early rheumatoid arthritis: Anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis. 2007, 66, 712-719.
46. Van den Steen, P. E., Proost, P., Grillet, B., Brand, D. D. et al., Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002, 16, 379-389.
47. Sinz, A., Bantscheff, M., Mikkat, S., Ringel, B. et al., Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002, 23, 3445-3456.
48. Dotzlaw, H., Schulz, M., Eggert, M., Neeck, G., A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta 2004, 14, 121-129.
49. Drynda, S., Ringel, B., Kekow, M., Kuhne, C. et al., Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol. Res. Pract. 2004, 200, 165-171.
50. Kantor, A. B., Wang, W., Lin, H., Govindarajan, H. et al., Biomarker discovery by comprehensive phenotyping for autoimmune diseases. Clin. Immunol. 2004, 111, 186-195.
51. Uchida, T., Fukawa, A., Uchida, M., Fujita, K. et al., Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J. Proteome Res. 2002, 1, 495-499.
52. de Seny, D., Fillet, M., Meuwis, M. A., Geurts, P. et al., Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum. 2005, 52, 3801-3812.
53. de Seny, D., Fillet, M., Ribbens, C., Marée, R. et al., Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin. Chem. 2008, 54, 1066-1075.
54. Doherty, N. H., Littman, B. H., Reilly, K., Swindell, A. C. et al., Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 1998, 19, 355-363.
55. Smith, M. A., Bains, S. K., Betts, J. C., Choy, E. H., Zanders, E. D., Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4. Clin. Diagn. Lab. Immunol. 2001, 8, 105-111.
56. Fuchs, B., Schiller, J., Wagner, U., Hantzschel, H., Arnold, K., The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by 31P NMR and MALDI-MS. Clin. Biochem. 2005, 38, 925-933.
57. Takeuchi, T., Nakanishi, T., Tabushi, Y., Hata, A. et al., Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 855, 66-70.
58. Sekigawa, I., Yanagida, M., Iwabuchi, K., Kaneda, K. et al., Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin. Exp. Rheumatol. 2008, 26, 261-267.
59. Yamagiwa, H., Sarkar, G., Charlesworth, M. C., McCormick, D. J., Bolander, M. E., Two-dimensional gel electrophoresis of synovial fluid: Method for detecting candidate protein markers for osteoarthritis. J. Orthop. Sci. 2003, 8, 482-490.
60. Gobezie, R., Kho, A., Krastins, B., Sarracino, D. A. et al., High abundance synovial fluid proteome: Distinct profiles in health and osteoarthritis. Arthritis Res. Ther. 2007, 9, R36.
61. Kamphorst, J. J., van der Heijden, R., DeGroot, J., Lafeber, F. P. et al., Profiling of endogenous peptides in human synovial fluid by nanoLC-MS: Method validation and peptide identification. J. Proteom. Res. 2007, 6, 4388-4396.
62. Steinbeck, M J., Nesti, L. J., Sharkey, P. F., Parvizi, J., Myeloperoxidase and chlorinated peptides in osteoarthritis: Potential biomarkers of the disease. J. Orthop. Res. 2007, 25, 1128-1135.
63. Xiang, Y., Sekine, T., Nakamura, H., Imajoh-Ohmi, S. et al., Proteomic surveillance of autoimmunity in osteoarthritis: Identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum. 2004, 50, 1511-1521.
64. Xiang, Y., Sekine, T., Nakamura, H., Imajoh-Ohmi, S. et al., Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol. 2006, 176, 3196-3204.
65. Li, Q. Z., Xie, C., Wu, T., Mackay, M. et al., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115, 3428-3439.
66. Bauer, J. W., Baechler, E. C., Petri, M., Batliwalla, F. M. et al., Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 2006, 3, e491.
67. Pavón, E. J., Muñoz, P., Lario, A., Longobardo, V. et al., Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006, 6, S282-S292.
68. Rovin, B. H., Song, H., Hebert, L. A, Nadasdy, T. et al., Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int. 2005, 68, 1825-1833.
69. Oates, J. C., Varghese, S., Bland, A. M., Taylor, T. P. et al., Prediction of urinary protein markers in lupus nephritis. Kidney Int. 2005, 68, 2588-2592.
70. Mosley, K., Tam, F. W., Edwards, R. J., Crozier, J. et al., Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford) 2006, 45, 1497-1504.
71. Rovin, B. H., Birmingham, D. J., Nagaraja, H. N., Yu, C. Y. et al., Biomarker discovery in human SLE nephritis. Bull. NYU Hosp. Jt. Dis. 2007, 65, 187-193.
72. Suzuki, M., Ross, G. F., Wiers, K., Nelson, S. et al., Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr. Nephrol. 2007, 22, 2047-2057.
73. Zhang, X., Jin, M., Wu, H., Nadasdy, T. et al., Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 2008, 17, 720-726.
74. Beeley, J. A, Khoo, K. S., Salivary proteins in rheumatoid arthritis and Sjögren's syndrome: One-dimensional and two-dimensional electrophoretic studies. Electrophoresis 1999, 20, 1652-1660.
75. Ryu, O. H., Atkinson, J. C., Hoehn, G. T., Illei, G. G. et al., Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006, 45, 1077-1086.
76. Giusti, L., Baldini, C., Bazzichi, L., Ciregia, F. et al., Proteome analysis of whole saliva: A new tool for rheumatic diseases- the example of Sjögren's syndrome. Proteomics 2007, 7, 1634-1643.
77. Hu, S., Wang, J., Meijer, J., Ieong, S. et al., Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 2007, 56, 3588-3600.
78. Peluso, G., De Santis, M., Inzitari, R., Fanali, C. et al., Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007, 56, 2216-2222.
79. Gilburd, B., Abu-Shakra, M., Shoenfeld, Y., Giordano, A. et al., Autoantibodies profile in the sera of patients with Sjogren's Syndrome: The ANA evaluation-a homogeneous, multiplexed system. Clin. Dev. Immunol. 2004, 11, 53-56.
80. Tomosugi, N., Kitagawa, K., Takahashi, N., Sugai, S. et al., Diagnostic potential of tear proteomic patterns in Sjögren's syndrome. J. Proteome Res. 2005, 4, 820-825.
81. Fietta, A. M., Bardoni, A. M., Salvini, R., Passadore, I. et al., Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res. Ther. 2006, 8, R160-R170.
82. Giusti, L., Bazzichi, L., Baldini, C., Ciregia, F. et al., Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J. Rheumatol. 2007, 34, 2063-2069.
83. Xiang, Y., Matsui, T., Matsuo, K., Shimada, K. et al., Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis. Arthritis Rheum. 2007, 56, 2018-2030.
84. Lee, K. H., Chung, H.-S., Kim, H. S., Oh, S.-H. et al., Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum. 2003, 48, 2025-2035.
85. Miyamae, T., Malehorn, D. E., Lemster, B., Mori, M. et al., Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res. Ther. 2005, 7, R746-R755.
86. Stone, J. H., Rajapakse, V. N., Hoffman, G. S., Specks, U. et al., A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. Arthritis Rheum. 2005, 52, 902-910.
87. Chen, Y.-C., Wang, P.-W., Pan, T.-L., Wallace, C. et al., Proteomic analysis of Down's syndrome patients with gout. Clin. Chim. Acta 2006, 1, 89-94.
88. Tan, X., Cai, D., Wu, Y., Rong, L. et al., Comparative analysis of serum proteomes: Discovery of proteins associated with osteonecrosis of the femoral head. Transl. Res. 2006, 148, 114-119.
89. Prahalad, A. K., Hickley, R. L., Huang, J., Hoelz, D. J. et al., Serum proteome profiles identifies parathyroid hormone physiologic response. Proteomics 2006, 6, 3482-3493.
90. Tanaka, Y., Nakamura, M., Matsui, T., Iizuka, N. et al., Proteomic surveillance of autoantigens in relapsing polychondritis. Microbiol. Immunol. 2006, 50, 117-126.
91. Singh, R., Shasany, A. K., Aggarwal, A., Sinha, S., Low molecular weight proteins of outer membrane of Salmonella typhimurium are immunogenic in Salmonella induced reactive arthritis revealed by proteomics. Clin. Exp. Immunol. 2007, 148, 486-493.
92. Djouad, F., Mrugala, D., Noël, D., Jorgensen, C., Engineered mesenchymal stem cells for cartilage repair. Regenerative Med. 2006, 1, 529-537.
93. Kubota, K., Wakabayashi, K., Matsuoka, T., Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: Two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography. Proteomics 2003, 3, 616-626.
94. Foster, L. J., Zeemann, P. A., Li, C., Mann, M. et al., Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 2005, 23, 1367-1377.
95. Chiellini, C., Cochet, O., Negroni, L., Samson, M. et al., Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol. Biol. 2008, 9, 26.
96. Lee, J. S., Lee, J. S., Roh, H. L., Kim, J. et al., Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: Comparative analysis according to the risk factor. J. Orthopaed. Res. 2007, 24, 604-609.
97. Scharstuhl, A., Schewe, B., Benz, K., Gaissmaier, C. et al., Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells 2007, 25, 3244-3251.
98. Ponte, A. L., Marais, E., Gallay, N., Langonné, A. et al., The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25, 1737-1745.
99. Kastrinaki, M.-C., Sidiropoulos, P., Roche, S., Ringe, J. et al., Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann. Rheum. Dis. 2008, 67, 741-749.
100. Rollín, R., Marco, F., Camafeita, E., Calvo, E. et al., Differential proteome of bone marrow mesenchymal stem cells from osteoarthritis patients. Osteoarthr. Cartilage 2008, 16, 929-935.